Antibody persistence and immune memory in healthy adults following vaccination with a two-dose inactivated hepatitis A vaccine: Long-term follow-up at 15 years

Journal of Medical Virology

Volumn 83, Issue 11, 2011, Pages 1885-1891

  van Herck, Koen ^a,b   Jacquet, Jeanne Marie ^c   van Damme, Pierre ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

Hepatitis A vaccine; Immune response; Persistence

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS A VACCINE;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; FEMALE; FOLLOW UP; HEPATITIS A; HEPATITIS A VIRUS; HUMAN; HUMAN EXPERIMENT; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOLOGICAL MEMORY; MALE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; VACCINATION;

ADOLESCENT; ADULT; BELGIUM; FEMALE; FOLLOW-UP STUDIES; HEPATITIS A ANTIBODIES; HEPATITIS A VACCINES; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOLOGIC MEMORY; MALE; VACCINATION; YOUNG ADULT;

HEPATITIS A VIRUS;

EID: 80052692759     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.22200     Document Type: Article

References (28)

1. André FE, Hepburn A, D'Hondt E. 1990. Inactivated candidate vaccines for hepatitis A. Prog Med Virol 37: 72-95.
2. André F, Van Damme P, Safary A, Banatvala J. 2002. Inactivated hepatitis A vaccine: Immunogenicity, efficacy, safety and review of official recommendations for use. Expert Rev Vaccines 1: 9-23.
3. Berge JJ, Drennan DP, Jacobs RJ, Jakins A, Meyerhoff AS, Stubblefield W, Weinberg M. 2000. The cost of hepatitis A infections in American adolescents and adults in 1997. Hepatology 31: 469-473.
4. Berger R, Just M, Althaus B. 1993. Time course of hepatitis A antibody production after active, passive and active/passive immunization: The results are highly dependent on the antibody test system used. J Virol Methods 43: 287-297.
5. Bovier PA, Bock J, Loutan L, Farinelli T, Glueck R, Herzog C. 2002. Long-term immunogenicity of an inactivated virosome hepatitis A vaccine. J Med Virol 68: 489-493.
6. Bovier PA, Farinelli T, Bock J, Herzog C, Glaus J, Ibanez R, Loutan L. Ten year immunogenicity of a virosome-adjuvanted hepatitis A vaccine. 9th Conference of the International Society of Travel Medicine (CISTM), Lisbon Portugal, May 1-5, 2005. Program and Book of Abstracts. Available at: Accessed June 2011.
7. Chin J, editor. 2000. Control of communicable diseases manual. 17th edition. Washington, DC: American Public Health Association.
8. Chodick G, Heymann AD, Ashkenazi S, Kokia E, Shalev V. 2008. Long-term trends in hepatitis A incidence following the inclusion of hepatitis A vaccine in the routine nationwide immunization program. J Viral Hepat 15: 62-65.
9. Daniels D, Grytdal S, Wasley A, Centers for Disease Control Prevention (CDC). 2009. Surveillance for acute viral hepatitis - United States, 2007. MMWR Surveill Summ 58: 1-27.
10. Delem AD. 1992. Comparison of modified HAVAB and ELISA for determination of vaccine-induced anti-HAV response. Biologicals 20: 289-291.
11. Domínguez A, Oviedo M, Carmona G, Jansá JM, Borrás E, Salleras L, Plasència A. 2008. Epidemiology of hepatitis A before and after the introduction of a universal vaccination programme in Catalonia, Spain. J Viral Hepat 15: 51-56.
12. Hammitt LL, Bulkow L, Hennessy TW, Zanis C, Snowball M, Williams JL, Bell BP, McMahon BJ. 2008. Persistence of antibody to hepatitis A virus 10 years after vaccination among children and adults. J Infect Dis 198: 1776-1782.
13. López EL, Contrini MM, Mistchenko A, Debbag R. 2010. Long-term immunity after two doses of inactivated hepatitis A vaccine in Argentinean children. Pediatr Infect Dis J 29: 568-570.
14. Luyten J, Beutels P. 2009. Costing infectious disease outbreaks for economic evaluation: A review for hepatitis A. Pharmacoeconomics 27: 379-389.
15. Nothdurft HD. 2008. Hepatitis A vaccines. Expert Rev Vaccines 7: 535-545.
16. Rendi-Wagner P, Korinek M, Winkler B, Kundi M, Kollaritsch H, Wiedermann U. 2007. Persistence of seroprotection 10 years after primary hepatitis A vaccination in an unselected study population. Vaccine 25: 927-931.
17. Vacchino MN. 2008. Incidence of hepatitis A in Argentina after vaccination. J Viral Hepat 15: 47-50.
18. Van Damme P, Matheï C, Thoelen S, Meheus A, Safary A, André FE. 1994. Single dose inactivated hepatitis A vaccine: Rationale and clinical assessment of the safety and immunogenicity. J Med Virol 44: 435-441.
19. Van Damme P, Banatvala J, Fay O, Iwarson S, McMahon B, Van Herck K, Shouval D, Bonanni P, Connor B, Cooksley G, Leroux-Roels G, Von Sonnenburg F, International Consensus Group on Hepatitis A Virus Immunity. 2003. Hepatitis A booster vaccination: Is there a need? Lancet 362: 1065-1071.
20. Van Herck K, Beutels P, Van Damme P, Beutels M, Van den Dries J, Briantais P, Vidor E. 2000. Mathematical models for assessment of long-term persistence of antibodies after vaccination with two inactivated hepatitis A vaccines. J Med Virol 60: 1-7.
21. Van Herck K, Van Damme P. 2001. Inactivated hepatitis A vaccine-induced antibodies: Follow-up and estimates of long-term persistence. J Med Virol 63: 1-7.
22. Van Herck K, Van Damme P, Lievens M, Stoffel M. 2004. Hepatitis A vaccine: Indirect evidence of immune memory 12 years after the primary course. J Med Virol 72: 194-196.
23. Van Herck K, Van Damme P. 2005. Prevention of hepatitis A by Havrix: A review. Expert Rev Vaccines 4: 459-471.
24. Wasley A, Fiore A, Bell BP. 2006. Hepatitis A in the era of vaccination. Epidemiol Rev 28: 101-111.
25. World Health Organization. 1995. Public health control of hepatitis A: Memorandum from a WHO meeting. Bull World Health Organ 73: 15-20.
26. World Health Organization. 2000. Hepatitis A vaccines. WHO position paper. Wkly Epidemiol Rec 75: 38-44.
27. World Health Organization. 2008. Hepatitis A. Fact F Sheet No. 328, May 2008. Available at: Accessed June 2011.
28. World Health Organization. 2009. The global prevalence of hepatitis A virus infection susceptibility: A systemic review. Available at: Accessed June 2011.